Skip to main content

Newsroom

Latest News

February 29, 2012

Washington, D.C. – Democratic Leader Nancy Pelosi, Congresswoman Louise Slaughter, Congresswoman Rosa DeLauro, Congresswoman Eleanor Holmes-Norton, Congresswoman Carolyn Maloney, Congressman Elijah Cummings and Congresswoman Diana DeGette released the following statement on the vicious and inappropriate attacks leveled on Ms. Sandra Fluke today. Last week, Democratic Leader Nancy Pelosi and the House Democratic Steering and Policy Committee held a hearing on the issue of women’s health, hearing testimony from Ms. Fluke, a third-year law student at Georgetown University.

February 26, 2012

DENVER – U.S. Rep. Diana DeGette (CO-1) today issued the following statement regarding U.S. Senator Mark Udall’s announcement of a process to create wilderness designations in Colorado.

February 21, 2012

WASHINGTON – U.S. Rep. Diana DeGette (D-CO) today issued the following statement in response to the Food and Drug Administration's (FDA) announcement of steps to increase the supply of critically needed cancer drugs, and build on President Obama's Executive Order to help prevent future drug shortages. DeGette is the author, along with U.S. Rep. Tom Rooney (R-FL), of the "Preserving Access to Life-Saving Medications Act," a bill to improve patient safety by reducing shortages of life-saving drugs.

February 17, 2012

WASHINGTON – U.S. Rep. Diana DeGette (CO-1) issued the following statement today after the 10th Circuit Court of Appeals denied a request for a rehearing that sought to overturn the Clinton Era Roadless Rule. The appellants – the State of Wyoming and the Colorado Mining Association – now have 90 days to file a petition for certiorari to the U.S. Supreme Court.

February 17, 2012

WASHINGTON, DC — Today Reps. Henry A. Waxman, Diana DeGette, Frank Pallone, Jr., Rosa L. DeLauro, and Carolyn B. Maloney sent a letter to FDA Commissioner Margaret Hamburg urging the agency to take action on recommendations by the FDA’s General and Plastic Surgery Devices Panel. Over two years ago, the panel recommended many safeguards that FDA could implement to protect consumers from the serious and deadly cancer risks posed by tanning beds.

February 17, 2012

WASHINGTON – U.S. Rep. Diana DeGette (CO-1) issued the following statement after voting for the Conference Report to H.R. 3630, the Temporary Payroll Tax Cut Continuation Act of 2011. The bill passed the House of Representatives 293 to 132.

February 10, 2012
DENVER – U.S. Rep. Diana DeGette (CO-1) issued the following statement today after the White House announcement on preventive care services for women.

“I am pleased that today the White House reaffirmed that universal coverage of contraception for women is a central tenet of essential women’s health care. This announcement helps ensure that millions of people and their dependents will have access to critical health care.

February 7, 2012

WASHINGTON – U.S. Rep. Diana DeGette (CO-1), Vice-Chair of the Congressional LGBT Caucus, issued the following statement after the U.S. Court of Appeals for the Ninth Circuit ruled that California’s Proposition 8 banning same sex marriage was unconstitutional.

February 3, 2012

WASHINGTON – U.S. Rep. Diana DeGette (CO-1) today issued the following statement regarding the Susan G. Komen Foundation’s reversal of their policy stopping funding grants for Planned Parenthood.

February 2, 2012
Washington, DC - Congresswoman Diana DeGette (D-CO), Congressman Maurice Hinchey (D-NY), and Congressman Jared Polis (D-CO) today asked President Obama to back stronger environmental and public health standards to protect against the risks of hydraulic fracturing. In a letter, the House members requested the President's support for the Fracturing Responsibility and Awareness of Chemicals (FRAC) Act, which would require the disclosure of chemicals used in the hydraulic fracturing natural gas extraction process.